Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
1.64
Dollar change
+0.07
Percentage change
4.78
%
Index- P/E- EPS (ttm)-10.69 Insider Own5.24% Shs Outstand4.48M Perf Week2.17%
Market Cap7.71M Forward P/E- EPS next Y-17.00 Insider Trans0.04% Shs Float4.24M Perf Month0.92%
Income-7.39M PEG- EPS next Q-2.38 Inst Own0.81% Short Float5.39% Perf Quarter-35.24%
Sales0.00M P/S- EPS this Y2.93% Inst Trans-5.89% Short Ratio0.13 Perf Half Y-77.34%
Book/sh-1.41 P/B- EPS next Y-19.13% ROA-344.10% Short Interest0.23M Perf Year-89.39%
Cash/sh0.25 P/C6.48 EPS next 5Y- ROE-4408.31% 52W Range1.40 - 20.00 Perf YTD-81.52%
Dividend Est.- P/FCF- EPS past 5Y-11.45% ROI- 52W High-91.78% Beta-0.04
Dividend TTM- Quick Ratio0.49 Sales past 5Y0.00% Gross Margin- 52W Low17.50% ATR (14)0.15
Dividend Ex-Date- Current Ratio0.49 EPS Y/Y TTM54.63% Oper. Margin0.00% RSI (14)45.33 Volatility4.93% 7.77%
Employees7 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price50.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q76.70% Payout- Rel Volume0.06 Prev Close1.57
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsSep 10 Avg Volume1.72M Price1.64
SMA200.98% SMA50-11.16% SMA200-69.88% Trades Volume110,327 Change4.78%
Date Action Analyst Rating Change Price Target Change
Oct-01-21Initiated Ascendiant Capital Markets Buy $8
Oct-16-24 08:00AM
07:30AM
Oct-15-24 08:00AM
Oct-10-24 08:00AM
Aug-26-24 08:00AM
08:00AM Loading…
Aug-19-24 08:00AM
Aug-12-24 08:00AM
Aug-06-24 08:00AM
05:32AM
Aug-05-24 09:09AM
07:30AM
Jul-31-24 08:00AM
Jul-12-24 08:00AM
May-22-24 08:00AM
May-14-24 08:00AM
09:30AM Loading…
May-09-24 09:30AM
08:00AM
May-07-24 08:00AM
Apr-02-24 05:41PM
Mar-26-24 05:52AM
Dec-18-23 12:03PM
12:03PM
Dec-11-23 09:30AM
08:00AM
Nov-20-23 08:00AM
Nov-16-23 08:00AM
Nov-13-23 08:00AM
Oct-30-23 08:00AM
Oct-23-23 09:31AM
08:00AM
09:30AM Loading…
Oct-02-23 09:30AM
08:00AM
Sep-22-23 08:00AM
Aug-30-23 09:30AM
08:00AM
Jun-22-23 09:30AM
08:00AM
Jun-13-23 08:00AM
May-24-23 08:00AM
May-11-23 12:38PM
Apr-04-23 06:30AM
Apr-03-23 09:35AM
09:34AM
08:50AM
Mar-22-23 09:30AM
08:00AM
Mar-17-23 07:09AM
Mar-16-23 08:00AM
Jan-26-23 08:00AM
Jan-04-23 08:00AM
Dec-28-22 08:00AM
07:31AM
Dec-13-22 03:52PM
Nov-22-22 08:05AM
Nov-15-22 08:00AM
Oct-31-22 08:00AM
Oct-11-22 10:03AM
Oct-05-22 12:45PM
08:00AM
Sep-29-22 12:29PM
08:00AM
Sep-22-22 08:00AM
Aug-25-22 07:13AM
Jul-24-22 08:41AM
Jul-18-22 10:42AM
08:00AM
Jun-20-22 09:22AM
Jun-03-22 08:00AM
May-17-22 08:00AM
May-06-22 09:02AM
May-05-22 08:00AM
May-04-22 06:25AM
Apr-28-22 06:30AM
06:30AM
Apr-11-22 08:00AM
Apr-06-22 10:15AM
Apr-04-22 08:00AM
Mar-28-22 08:00AM
Mar-18-22 06:31AM
Jan-13-22 04:00AM
Dec-17-21 09:54AM
09:00AM
Dec-14-21 06:35PM
11:18AM
09:29AM
Nov-30-21 08:30AM
Nov-11-21 07:17AM
Oct-01-21 09:24AM
04:44AM
Sep-30-21 01:45PM
12:09PM
11:54AM
10:11AM
Sep-16-21 06:09AM
Sep-15-21 06:29AM
Sep-13-21 06:30AM
Aug-17-21 10:59AM
08:00AM
Aug-04-21 06:30AM
Jul-30-21 06:30AM
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which is in Phase II clinical trial, and delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bipolar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders, and AL002, which completed preclinical stage, and uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AULT MILTON C IIIDirectorAug 06 '24Buy2.757520677,268Aug 14 06:01 PM
AULT MILTON C IIIDirectorJul 31 '24Buy3.74259377,193Aug 01 05:20 PM
AULT MILTON C IIIDirectorApr 19 '24Buy0.691,000688771,699Apr 23 08:00 PM
AULT MILTON C IIIDirectorApr 01 '24Buy0.91334304770,699Apr 03 05:00 PM
AULT MILTON C IIIDirectorJan 05 '24Buy1.062,0002,127770,365Apr 01 04:30 PM
AULT MILTON C IIIDirectorJan 05 '24Buy1.025,0005,092768,365Jan 09 04:30 PM
AULT MILTON C III10% OwnerDec 26 '23Buy0.9050045026,032Dec 27 04:30 PM
AULT MILTON C III10% OwnerDec 22 '23Buy0.92200185166,866Dec 27 04:30 PM